RheumNow

Best of 2025: Contraception in SLE Pregnancy in SLE gets a lot of press in the rheumatology literature, and deservedly […]

Sjogrens is a hot area in drug development: “Sjogren’s Syndrome Pipeline Insight 2025” report provides comprehensi https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/02/2026

Comprehensive review of the management of knee osteoarthritis – topicals, analgesics, narcotics, intraarticular, metabo https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/02/2026 – 18:30

Inflammatory vs. Noninflammatory Pain https://t.co/ZZLMnT8IVO https://t.co/W0tVK75raN https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Fri, 01/02/2026 – 16:00 RheumNow Dr. John Cush Inflammatory vs. Noninflammatory Pain

APP Pearls “When I’m explaining treatment options, I say “hey you are the captain of this ship, I’m your co-capt

Best of 2025: 2025 BSR Guideline for Treatment of Axial Spondyloarthritis jjcush@gmail.com Fri, 01/02/2026 – 08:00

Best of 2025: ERS/EULAR guidelines for CTD-related interstitial lung disease jjcush@gmail.com Wed, 12/31/2025 – 08:30

Best of 2025: Variability of Guidelines on the Perioperative Use of DMARDs in Rheumatic Diseases Patients jjcush@gmail.com Wed, 12/31/2025 –

Best of 2025: GRAPPA vs. EULAR on Complex/Difficult-to-Manage Psoriatic Arthritis nellziade@yahoo.fr Tue, 12/30/2025 – 08:00

Best of 2025: Targeting Obesity in Rheumatic Disease Patients jjcush@gmail.com Tue, 12/30/2025 – 09:00

Best of 2025: Contraception in SLE sammaritanol@hss.edu Mon, 12/29/2025 – 11:00

Best of 2025: Hydroxychloroquine for Everyone jjcush@gmail.com Mon, 12/29/2025 – 09:00

Best of 2025: Glossary for Giant Cell Arteritis jjcush@gmail.com Fri, 12/26/2025 – 08:15

Best of 2025: Glucocorticoids in SLE: how to start, how to follow, how to stop r.irastorza@ou… Fri, 12/26/2025 – 08:00

EULAR Classification criteria for hemachromatosis, presented by Prof. Kiely shows clinical pearls in diagnosis – Hook os https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed,

APP Pearls “Never stop learning—rheumatology is full of surprises” – Kayla Carlucci, FNP-BC https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 12/24/2025 – 16:00 RheumNow

BREAKING NEWS: How many patients with RA achieve and maintain remission with a JAKi? Find out in the RheumNow poster

Nerandomilast FDA Approved for Progressive Pulmonary Fibrosis The FDA has approved nerandomilast (Jascayd), a PDE4b in https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Wed, 12/24/2025

Three Things to Know About Hiring, Onboarding, and Training APPs As the utilization of APPs (nurse practitioners and p https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg

Best of 2025: Distinguishing Septic and Gouty Arthritis jjcush@gmail.com Wed, 12/24/2025 – 08:15

Best of 2025: Dermatomyositis Reviewed jjcush@gmail.com Wed, 12/24/2025 – 08:00

Telling You Where to Go (12.19.2025) Dr. Jack Cush reviews the news and journal articles from the past week on

Evaluation of Rheumatic Complaints https://t.co/3p3dtlUKpQ https://t.co/XseCMhvpnN https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/23/2025 – 18:30 RheumNow Dr. John Cush Evaluation of Rheumatic Complaints

Comorbidity and Health Management https://t.co/2jDcBmP4zt https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/23/2025 – 19:00 RheumNow Dr. John Cush Comorbidity and Health Management https://t.co/2jDcBmP4zt

APP Controversies and Misconceptions In this Tuesday Night Rheumatology, panelists discuss a range of topics, includin https://pbs.twimg.com/profile_images/1915149062988271616/2m4z_QPt_normal.jpg john+RNV2@john… Tue, 12/23/2025